Copper-based Microbiome Modulation for Expanded Health Applications

This inventive concept leverages the core technology of the original patent to develop novel applications for reducing the incidence and prevalence of various diseases and infections across multiple industries, including respiratory, neurodegenerative, skin, gastrointestinal, and cardiovascular health.

The original patent disclosed a method for reducing the incidence and prevalence of human papilloma virus (HPV) and providing protection against sexually transmitted infections. However, the patent's scope was limited to cervical cancer prevention. This inventive concept addresses the need for expanded applications of the core technology to tackle a broader range of diseases and infections, thereby increasing its potential impact on public health.

The inventive concept encompasses a family of devices and methods that utilize copper-based materials to modulate the microbiome in various parts of the body, such as the nasal cavity, oral cavity, skin, gut, and cardiovascular system. These devices and methods are designed to reduce inflammation, increase local immunity, and prevent the development of various diseases and infections. The copper-based materials are configured to have specific surface areas and geometries to optimize their interaction with the microbiome and achieve the desired therapeutic effects.

The new claims introduce novel applications of the core technology, including the use of copper-based devices for respiratory, neurodegenerative, skin, gastrointestinal, and cardiovascular health. These applications are non-obvious extensions of the original patent, as they require a deep understanding of the microbiome's role in various diseases and infections, as well as the development of specialized devices and methods tailored to each specific application.

Alternative embodiments of the inventive concept could include the use of different materials, such as silver or zinc, in place of copper. Additionally, the devices and methods could be adapted for use in veterinary medicine or agricultural applications. Furthermore, the inventive concept could be integrated with other therapeutic modalities, such as antimicrobial peptides or probiotics, to enhance its effectiveness.

The inventive concept has significant commercial potential in various industries, including pharmaceuticals, medical devices, and consumer health products. The target market includes individuals and healthcare providers seeking to prevent or treat diseases and infections, as well as companies developing products and services related to microbiome modulation. The market size is substantial, with potential applications in multiple sectors and geographic regions.